Congenital obstructive malformations of the ureter are amongst the most common human birth defects. To date, the etiology of these diseases has remained largely unexplored, which has preempted any rational approach for therapeutic intervention. Here, we describe that obstructive ureter defects can arise from genetic insults affecting various subprograms of ureter development including formation and patterning of the ureteric bud, differentiation of tissue compartments of the ureter, and junction formation with the bladder and pelvis. New experimental findings have highlighted the importance of epithelial-mesenchymal tissue interactions in all of these subprograms and provided unique insights into the molecular nature of the transcriptional regulators and signaling pathways involved.
The urinary system is a multicomponent entity, whose primary functions are (1) the maintenance of body homoeostasis by controlling the water and ionic balance of the blood, and (2) the excretion of excess water, solutes, and waste products. Anatomically, these functions are served by the composite design of an upper unit comprised of the kidneys, which filter and modify the blood, and a lower unit consisting of the ureters, the bladder, and the urethra, which drain the urine to the outside. The epithelial lining of the kidney is functionally adapted to ensure the selective secretion and resorption of solutes and water from the primary urine in renal tubules and collecting ducts, while the urothelium constitutes a specialized permeability barrier to urinary toxicity in the lower urinary tract. The urothelium of the ureter and bladder is heavily invested with smooth-muscle layers that provide structural rigidity, flexibility, and contractility.
Rather than being a simple, passive tubular outlet of the pelvis, the ureter represents a pivotal connection between the upper and lower urinary systems. After filling the renal pelvis with urine, the upper portion of the ureter undergoes unidirectional peristaltic contractions, triggered by pacemaker cells, to propel the urine down to the bladder, while preventing any reflux or efflux at the same time. The specialized anatomical design of the ureter interfaces with the pelvis and the bladder as well as the two-layered tissue architecture of the ureter tube itself ensure that these tasks are met.
The crucial importance of the ureter for renal function is dramatically reflected by acquired and inherited defects that interfere with the efficient removal of the urine from the renal pelvis. Any kind of anatomical or functional obstruction along the ureter or at its junctions will result in fluid pressure-mediated dilation of the tubular system proximal to the side of constriction. Obstruction may originate from physical barriers or compromised structural integrity and peristaltic activity of the ureter. Dilation of the ureter (hydroureter) will lead to dilation of the pelvis and collecting duct system of the kidney (hydronephrosis). This condition may progress to pressure-mediated destruction of the renal parenchyme and culminate in end-stage renal disease.
Since congenital obstructive malformations of the ureter are a leading cause of renal failure in children and young adults, development are prerequisite to the identification of the genetic aberrations underlying hydroureter/hydronephrosis and exploration of the disease etiology. In contrast to other organs such as the kidneys, our knowledge of the genetic control of ureterogenesis has been limited. However, recent experimental findings from gene expression studies, embryological manipulations, and particularly the phenotypic analysis of mouse mutants (see Table 1 for an overview) have resulted in the emergence of a more comprehensive picture of the genetic circuits acting during ureter development. Here, we will review the current status of ureter development by focusing on recent molecular studies that highlight the importance of tissue interactions for early ureter development and the etiology of obstructive nephropathies.
URETER DEVELOPMENT
Although the ureter is structurally and functionally part of the drainage system of the lower urinary tract, its ontogenetic origin is clearly distinct from that of the bladder and the urethra (see Figure 1 , first four columns, for the embryonic development of the ureter and its tissue compartments in the mouse). While the latter two arise from the endodermal urogenital sinus, ureters derive with the kidneys from the Wolffian duct in the intermediate mesoderm. At embryonic day (E)10.5 in mouse, an epithelial diverticulum called ureteric bud (UB) evaginates from the distally elongating Wolffian duct at the level of the hind limb buds and starts to grow toward an adjacent group of mesenchymal cells. After intrusion into this metanephric blastema, the tip of the UB acquires a drastically different fate from the 'stalk'-the portion remaining outside of the metanephros. The tip engages in repetitive rounds of elongation and branching and ultimately generates the collecting duct system of the kidney, whereas the stalk merely elongates to form the epithelial component of the ureter. From E12.5 on, the distal end of the stalk separates from the Wolffian duct and integrates into the developing bladder wall, which establishes continuity of the urinary tract. Starting at E15.5, the epithelium of the ureter stalk differentiates into the urothelium, which is then able to resist the toxicity of the urine being produced from E16.5 onwards. In parallel with the dichotomy of epithelial development, mesenchymal cells covering either region of the UB epithelium take completely different developmental routes. The metanephric mesenchyme surrounding the proximal tip regions undergoes a mesenchymal-epithelial transition to form nephrons and differentiates into interstitial mesenchyme or stroma, respectively. In contrast, the mesenchyme surrounding the ureter stalk differentiates into smooth-muscle cells that will form layers with longitudinal and transverse orientation. Finally, the establishment of the peristaltic machinery at the ureter-pelvis junction, the pyeloureteric region, ensures full functionality of the ureter at birth.
TAKING OFF: MESENCHYMAL CONTROL OF URETER BUDDING
Since formation of both ureter and metanephric kidney depend on ureter budding from the Wolffian duct, any disruption of this process will certainly have dramatic effects on either structure. Both embryological manipulations and genetic analyses have shown that the emergence of the ureteric bud is not determined by positional information intrinsic to the epithelial Wolffian duct, but that signals from the adjacent mesenchyme direct the outgrowth, setting a first paradigm for the importance of mesenchymal-epithelial interaction for ureter (and kidney) development. Since the regulation of ureter budding has been extensively reviewed in recent years, 36, 37 we will summarize the key findings that are relevant for ureter development. Temporal and spatial control of ureter budding is achieved by establishment of a mesenchymal signaling center at the posterior end of the intermediate mesoderm at around E10.0, shortly before the Wolffian duct has reached this position. Glial-derived neurotrophic factor (Gdnf) released from the metanephric blastema induces ureter budding and outgrowth from the Wolffian duct. Loss of any of the components of the network establishing and interpreting the Gdnf signal or the simple experimental separation of the Wolffian duct from the metanephric blastema disrupts or delays ureter budding and outgrowth, leading to ureter and kidney agenesis in the extreme and renal hypoplasia, or dysplasia in less severe cases.
Spatial restriction of Gdnf signaling is tightly controlled to ensure the localized appearance of a single UB (Figure 1e ). Genetic ablation of the genes encoding the transcription factors Foxc1 and Foxc2, 7 and the signaling system of the large secreted protein Slit2 and its receptor roundabout homolog2 (Robo2) 10 in the mesenchyme surrounding the Wolffian duct results in the expansion of the metanephric blastema and the region of Gdnf signaling. Ectopic activation of the Gdnf signal transduction pathway is likely to be caused by deletion of the signaling molecule bone morphogenetic protein 4 (Bmp4) 5, 6 and the angiotensin type II receptor 4 in the mesenchyme surrounding the Wolffian duct, the cytosolic factor Sprouty1, 11 the adhesion molecule L1cam, 8 and the transcription factor Nfia 9 in the Wolffian duct epithelium (see Table 1 , first section for a summary of mouse mutants with obstructive ureter malformations caused by ectopic ureter budding). Although it is still unclear how these transcriptional activities and signaling pathways are precisely interwoven to restrict Gdnf signaling spatially, phenotypic analyses of some of these mouse mutants have established that ectopic Gdnf signaling induces supernumerary ureteric buds. These will give rise to additional kidneys and ureters with improper connections to the bladder, leading to hydroureter and subsequent hydronephrotic lesions due to physical obstruction. 4, [6] [7] [8] 10, 11 PROXIMAL-DISTAL REGIONALIZATION OF THE URETERIC BUD IS UNDER MESENCHYMAL CONTROL Shortly after emerging from the Wolffian duct, the development of the epithelium and its surrounding mesenchyme at the two ends of the UB diverges. Which mechanisms direct the proximal-distal segmentation of the UB into the kidney and ureter? First, regionalization may rely on positional information acting independently and concomitantly in the two tissue compartments. If this were the case, separation and reverse recombination of mesenchyme and epithelium should not affect the fate of either region. Alternatively, the regional fate within one tissue compartment may depend on prior specification of the other compartment. In this case, the suggested transplantation experiments should result in fate reversal. Indeed, the latter case seems to be close to the truth. Tissue transplantation studies have demonstrated that proper development and functional specification of ureter tissues and other structures comprising the lower urinary tract critically depend on epithelial-mesenchymal signaling. When embryonic (E14.5) rat bladder mesenchyme is transplanted onto adult proximal ureter, formation of a second bladder is induced. 38 This and other experiments 39, 40 indicate that the mesenchyme controls the fate of the underlying epithelium, and that the epithelial compartment possesses considerable plasticity to respond to mesenchyme-derived instructive (Figure 1b) . We have recently shown that the T-box transcription factor gene Tbx18 is expressed in a band of mesenchymal cells located between the metanephric mesenchyme and the Wolffian duct in E11.5 mouse embryos. 23 At E12.5, Tbx18-expressing cells are exclusively found at the distal ureteric stalk (see Figure 1 , third column, for ureteric expression of Tbx18). Although genetic fate mapping of the E11.5 Tbx18-positive cell population has not been performed, short-term lineage tracing using a lacZ reporter integrated in the Tbx18 locus strongly argues that the ureteric mesenchyme is specified shortly after ureter budding, which is long before differentiation of the ureteric epithelium occurs. 23 Several papers, including a recent one by Brenner-Ananatharam 41 have confirmed and substantiated the role of Bmp4 in distal ureter-specific differentiation. Utilizing murine metanephric kidney cultures, they have shown that Bmp4 is required for ureter development, since smooth-muscle and urothelial differentiation are severely impaired after conditional inactivation of Bmp4. Bmp4 signaling in the periureteric mesenchyme seems also to be responsible for suppressing the morphogenetic program of the proximal UB in the distal stalk region. Lowering the concentration of active Bmp4 protein by application of recombinant protein of the Bmp antagonist Gremlin1 to a kidney/ureter explant system led to ectopic budding both from the Wolffian duct as well as from the distal ureter stalk, 43 confirming similar findings from Bmp4 heterozygous mice. 6 In a mouse explant system, ectopic Bmp4 has proved to be sufficient to induce smooth-muscle differentiation and urothelial differentiation in domains of the UB normally fated to differentiate into the intra-renal collecting system. 41 Taken together, these findings suggest that mesenchymal Bmp4 is both sufficient and required to induce ureter development from the UB, which is consistent with the notion that Bmp4 specifies the ureteric mesenchyme.
In an alternative approach, Brenner-Amarantham et al. 41 used cell labeling in the chick embryo to trace the lineage of the mesenchyme surrounding the ureteric bud. They confirmed that the metanephric mesenchyme derives from intermediate mesoderm caudal to somite 28. Surprisingly, lineage-tagged cells were not found in the mesenchyme surrounding the ureter. Instead, labeling of mesodermal cells from more caudal regions (designated 'tail-bud') resulted in large populations of tagged cells appearing in the mesenchyme surrounding the cloaca and the ureter. The tagged cells were never contributing to nephrons, suggesting distinct origins of the mesenchymal cells surrounding the proximal and distal aspects of the ureteric bud. Intriguingly, the temporal and spatial expression pattern of Bmp4 in chicks parallels the movement of the tail bud-derived mesenchyme, which will eventually engulf the epithelia of the entire lower urinary system. These findings are highly significant, as they for the first time provide evidence indicating that the mesenchymal cells lining the lower urinary tract are developmentally continuous and that Bmp4 is likely to be a common signal to trigger smooth muscle differentiation, and possibly urothelial differentiation throughout the lower urinary system. Clearly, the lineage-tracing studies need to be confirmed and extended to mammalian animal models, where tracing of expression domains, such as that of Bmp4, is technically feasible. Additionally, conditional tissue-specific inactivation of Bmp4 at different time points is needed to stringently test the roles of Bmp4 in the lower urinary tract. It is presently unclear whether the Bmp4-expressing cell population is a homogenous group of cells that is specified to become ureteric mesenchyme at the time of migration, or whether specification occurs later as a response to local cues. It is tempting to favor the latter hypothesis, as the Bmp4 expression domain is subdivided into a domain that flanks the metanephric blastema and expresses Tbx18, and a second domain adjacent to the Wolffian duct, which is devoid of Tbx18 (Figure 1h and j) . 23 Our molecular analysis has shown that Bmp4 expression is unaltered in the urinary system of Tbx18-deficient E11.5 embryos (unpublished observations). However, expression of Bmp4 starts to decline at E12.5, suggesting that Tbx18 maintains rather than establishes Bmp4 expression. 23 Since Tbx18 expression has not been analyzed in the urinary systems of Bmp4 mutant mice, the epistatic relationship of Tbx18 and Bmp4 remains unknown. It seems conceivable, however, that Bmp4 alone or in combination with positively or negatively acting local signals confers the spatially restricted Tbx18 expression, which will define prospective ureteric mesenchymal cells. While the metanephric mesenchyme has recently been excluded as a signaling center required for ureter development, 44 a source bladder; E, embryonic day; k, kidney; mm, metanephric mesenchyme; SM, smooth muscle; te, testis; ub, ureteric bud; ue, ureteric epithelium; um, ureteric mesenchyme; UGS, urogenital system; ut, ureteric tip; Wd, Wolffian duct.
of such a local signal might be the Wolffian duct. More generally, Bmp4 signaling in the lower urinary tract mesenchyme may be translated into regional programs of transcription factor activities that determine the distinct cell fates found in the ureter, bladder, and urethra. In this respect, Tbx18 misexpression experiments directed to the bladder mesenchyme might answer the question whether Tbx18 is sufficient to impose ureteric mesenchyme fate to the lower urinary tract. In a comparable experimental setting in the somitic mesoderm, Tbx18 was readily able to expand anterior at the expense of posterior somite halves. 45 Phenotypic analysis of Tbx18-mutant mice has shown that prospective ureteric mesenchyme fails to condense and hence disperses onto nearby tissues including the surface of the kidneys. 23 Therefore, the regulation of aggregation of prospective periureteric cells might be an important function of Tbx18. Separation of mesenchymal cell populations can be achieved by selective adhesion or by repulsive interactions. Although the existence of either mechanism has not yet been experimentally tested, boundary formation between the ureteric mesenchyme and the adjacent mesenchymal cell populations is of great importance. Ultimately, it restricts the extent of Bmp4 signaling and hence defines the proximal boundary of the ureter program. As the expression of Tbx18 continues in condensed mesenchymal cells, it may be required for maintaining borders at the points of intersection with the kidney and bladder. Loss of coherence of these mesenchymal cell populations could translate into defects of the ureter junctions. In this respect, Tbx18 might not only regulate the temporal duration of Bmp4 signaling, but also limit its spatial spread. Additional control of Bmp4 signaling may be provided by the gene encoding the Bmp agonist Bmper (Cv2), whose expression has recently been detected in the ureteric mesenchyme. 46, 47 Despite the exciting new insights gained by the analysis of Tbx18 and Bmp4 functions in ureter formation, we have just had a first glimpse of the molecular complexity involved in early specification and differentiation of the ureteric mesenchyme. To date, only a limited number of genes with restricted expression in the ureteric mesenchyme have been discovered. A role for Wnt signaling in ureter development has been implicated based on the Tbx18-dependent expression of the Wnt-binding protein sFRP2 in the ureteric mesenchyme. 23 Furthermore, mouse mutants have suggested additional roles for several transcription factors (see Table 1 , second section, for a list of mouse mutants with defects in specification and maturation of the ureter). Gata2-deficient mice have megaureter and severe hydroureternephrosis as a result of obstructive ureter malformation. 19 Expression of Gata2, which occurs both in the epithelium and the mesenchyme of the ureter, has precluded the assignment of the primary function of Gata2 to one of the two compartments. Interestingly, recent evidence suggests that Gata2 may act as a direct target of Bmp signaling. 48 Furthermore, expression of Id2, which represents another candidate target of Bmp signaling, is detected in the mesenchyme and later in the smooth muscle layer of the ureter. Remarkably, Id2-mutant mice (even in the heterozygous case) present with hydronephrosis, which is possibly caused by increased smooth-muscle proliferation in the pyeloureteric region. 20 Taken together, analysis of the role of Bmp4-signaling and Tbx18 transcriptional activity has provided decisive insight into the molecular control of the specification of the ureteric mesenchyme and its importance in directing distalization of the UB. Failure to specify the ureteric mesenchyme will compromise ureter development and lead to functional obstructive malformation.
RECIPROCAL EPITHELIAL-MESENCHYMAL SIGNALING DRIVES URETER MATURATION
With the completion of UB regionalization, a short ureter tube with layers of undifferentiated epithelial and mesenchymal cells has been established by E12.0. Maturation of this simple tube is likely to be governed by reciprocal signaling between the two tissue compartments (Figure 1o and t) . The crucial importance of epithelial signaling for further mesenchymal development was recently demonstrated by analysis of Sonic hedgehog (Shh)-mutant mice. 21 Starting from around E11.5, Shh expression is found in the ureteric epithelium. Expression of the Shh receptor Patched1 in the surrounding mesenchyme suggests a paracrine mode of action. Indeed, tissue-specific ablation of Shh in Wolffian duct derivatives leads to dramatic defects in the ureteric mesenchyme. Smooth-muscle differentiation is delayed; smooth muscle cells are less condensed and dramatically reduced in number, explaining the severely hypoplastic hydroureter phenotype of the mutant mice. Expression of Bmp4 is completely lost in Shh-mutant ureters, suggesting that Shh is required to maintain Bmp4 expression in the ureteric mesenchyme. Since Bmp4 is a potent inducer of mesenchymal cell aggregation and smooth-muscle differentiation in vitro, loss of Bmp4 expression may explain the smooth-muscle defects in Shh-deficient mice. 6, 21, 49 Importantly, the Bmp4 requirement seems to be confined to a small time window before E12.5, as the abolishment of Bmp4 at later stages does not affect smooth-muscle differentiation in a kidney/ureter explant culture system. 41 Besides inducing Bmp4 expression, Shh directly inhibits smooth-muscle differentiation of ureter mesenchyme in vitro. 21 This fact, along with the finding that smooth-muscle differentiation, which proceeds from proximal to distal, occurs only from E14.5 onwards, therefore argues against a simple relationship between Shh signaling, Bmp4 expression, and smooth-muscle differentiation. Since Shh has a proliferative effect on ureteric mesenchyme, 21 Shh signaling might be required to enlarge the pool of mesenchymal precursor cells before the onset of smooth-muscle differentiation. Independent of whether Bmp4 or other secreted factors induce smooth-muscle differentiation, Bmp4 signaling seems to be tightly controlled spatially and temporally. Tbx18-deficient ureters do no longer express Ptch1, which may explain the failure to maintain Bmp4 expression in the mesenchyme. Loss of Shh and Bmp4 signaling may therefore account for the defects in ureter maturation, including lack of smooth muscle cells and urothelial differentiation, observed in Tbx18-deficient mice. 23 Interestingly, Tbx18 expression in the mesenchyme is lost at the onset of smooth-muscle differentiation. 23 A possible requirement for Tbx18 in maintaining cells in an undifferentiated proliferative state and in preventing terminal differentiation may be tested by prolonged expression of Tbx18 in ureteric mesenchyme. Similarly, Tbx18 expression is also lost from mesenchymal condensations in the limb bud mesoderm before the onset of chondrogenic differentiation. 50 A further facet of the phenotype of Tbx18-deficient ureters is the fact that the urothelium is not formed. 23 This is compatible with the notion that signals from smooth muscle cells are required to induce and possibly maintain epithelial differentiation of the urothelium. Although Bmp4 signaling has been implicated in ureteric epithelial differentiation in vitro, we believe that a direct inductive role of Bmp4 is unlikely. As mentioned before, Bmp4 expression in the ureteric mesenchyme precedes urothelial differentiation by several days, arguing for additional mesenchymal signals downstream of Bmp4. Impairment of urothelial differentiation compromises ureter function, as shown by the hydroureter phenotype of mice mutant for Uroplakin3a and Uroplakin2. 24, 25 Uroplakins are a group of integral membrane proteins that form two-dimensional crystals (urothelial plaques) covering 90% of the apical urothelial surface.
Thus, differentiation defects in both mesenchymal and epithelial ureter compartments result in functional obstructive nephropathy.
Ureter elongation requires tight coupling of the growth and differentiation pathways acting in the mesenchymal and epithelial compartments. Disruption of Shh expression in the urinary system results in reduced proliferation of the surrounding mesenchyme, causing organ-specific hypoplasia. 21, 51 The mitogenic activity of Shh in the ureteric mesenchyme is independent of Bmp4, which rather appears to act as an antiproliferative agent. 21 Normal proliferation rates in the periureteric mesenchyme are not maintained in Tbx18-mutant ureters. This defect is most likely caused by the downregulation of Patched1 and Shh signaling in the mesenchyme. As a consequence, proliferation in the ureteric epithelium is also severely reduced, leading to early cessation of ureter elongation. 23 The fact that two independent molecular defects originating in different tissues present with similar mutant phenotypes confirms the assumption that reciprocal signaling between the epithelium and mesenchyme is required for the coordination of ureter growth.
Recently, two interesting studies have implicated the tumor suppressor gene disc large homologue 1 (Dlgh1) in the cross-talk between the ureteric epithelium and mesenchyme. 16, 17 Dlgh1 is a member of the membrane-associated guanylate kinase scaffolding proteins that contain three PSD-95/Dlg/ZO-1 (PDZ) domains. Dlgh1 is expressed in both the compartments of the ureter, although the expression levels are significantly higher in the urothelium. Dlgh1 mutant mice develop a short hydroureter and hydronephrosis at birth. The mesenchymal compartment is severely disorganized, with a lack of ureteric stromal cells. Furthermore, disorientation of the circular smooth-muscle cells in a longitudinal direction with subsequent defects in peristalsis is observed. 16 Since the formation and maintenance of the ureteric stromal cells, which separate the smooth muscle from the urothelium, depends on Shh signaling from the ureteric epithelium, 21 it is surprising that Shh signaling is normal in Dlgh1-deficient ureters. Hence, Dlgh1 seems to play an important Shhindependent function in the radial patterning of the ureteric mesenchyme. Iizuka-Kogo et al. 17 noted decreased proliferation in the ureteric epithelium of E12.5 Dlgh1-deficient embryos, suggesting an additional cell or tissue-autonomous function of Dlgh1.
Taken together, a number of reciprocal signaling systems operate between the epithelial and mesenchymal tissue compartment during ureter development, to coordinate proliferation and differentiation in time and space. Disruption of these signaling systems will lead to disturbed ureter elongation, tissue patterning, and differentiation that give rise to functional ureter obstruction.
GETTING CONNECTED: SIGNALING FOR TUBULAR JUNCTIONS
While the maturation of the ureter tube requires tight coordination between the epithelial and mesenchymal tissue compartments, generating functional connections with the proximal kidney and the distal bladder constitutes a ménage à trois, if not à quattre, that poses an even higher coordinative challenge. The tasks are however clearly very different for the two ends of the tube. At the proximal end, a continuous lumen between the collecting duct system and the pelvis on one side and the ureter on the other side is a mere consequence of their common origin from the ureteric bud. However, formation of the pyeloureteric peristaltic machinery is required to functionally connect the ureter and the pelvis. This process is initiated around birth and requires reciprocal interactions between the urothelium and the pyeloureteric mesenchyme (Figure 1y ). The intracellular protein phosphatase calcineurinB1 is an important component in this tissue communication process. 30 Mice lacking calcineurinB1 in the ureteric mesenchyme develop hydroureternephrosis due to smooth-muscle dysplasia and subsequent lack of the pyeloureteric peristaltic machinery. The mechanisms underlying this phenotype are not known. One possibility is that calcineurinB1 mediates angiotensin signaling, since disruption of either angiotensinogen, the precursor of the angiotensin peptides; renin, the enzyme generating angiotensin I from angiotensinogen; ace, the enzyme generating angiotensin II from angiotensinogen; or angiotensin II receptor all result in a similar phenotype. 52 Alternatively, calcineurinB1 may be involved in the regulation of Bmp signaling.
The situation is more delicate at the distal end of the ureter, since the growing ureter has to be inserted into the developing wall of the bladder to generate a valve-like opening that ensures exit of the urine into the bladder but avoiding vesiculoureteric reflux. Recent findings suggest that the transposition of the ureter from the Wolffian duct into the bladder wall involves apoptosis of the common nephric duct, the joint ending of the Wolffian duct and ureter. 31 Analysis of Rara-, Rarb-, and c-ret-mutant mice has implicated retinoic acid signaling originating from the proximal bladder wall as a driving force in this process during distal ureter maturation. 31, 32, 34 Thus, failure to physically and functionally connect the ureter to the bladder and renal pelvis are likely to arise from defects in signaling between the tissues involved. Once again, obstructive nephropathy will be at the end of developmental anomalies concerning tissue interactions.
CONCLUDING REMARKS
The phenotypic characterization of an increasing number of mouse mutants with urinary tract anomalies has brought the ureter into the limelight by identifying it as a sophisticated structural and functional component of the urinary system that arises as the result of a delicate interplay of various cell lineages during development. Disturbances of the communication between the principal cell lineages are likely to underlie the anomalies of the ureter. Analysis of the origin and fate of the cell lineages constituting the ureter, identification and characterization of genes specifically expressed in the various lineages, and detailed molecular analysis of existing and newly generated mouse models will undoubtedly provide a better picture of ureter development in the future. At its best, analysis of the molecular program governing ureterogenesis will provide a simple paradigm for tissue interactions in vertebrate tubulogenesis. From a clinical point of view, it will shed light on the etiology of congenital obstructive nephropathy and open new therapeutic avenues.
